The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial

Introduction. Chronic low back pain (LBP) has a wide range of causes. However, most cases are induced by degeneration of the lumbar intervertebral discs (IVDs), and the aching caused by local compression of the affected region has considerable impacts on quality of life. This clinical trial investig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wen-Cheng Lo, Yu Ting Chen, Chen Ching Chen
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/907634213bff47689b46eb3977738594
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:907634213bff47689b46eb3977738594
record_format dspace
spelling oai:doaj.org-article:907634213bff47689b46eb39777385942021-11-22T01:09:30ZThe Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial1748-671810.1155/2021/5824956https://doaj.org/article/907634213bff47689b46eb39777385942021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5824956https://doaj.org/toc/1748-6718Introduction. Chronic low back pain (LBP) has a wide range of causes. However, most cases are induced by degeneration of the lumbar intervertebral discs (IVDs), and the aching caused by local compression of the affected region has considerable impacts on quality of life. This clinical trial investigated the use of Elgucare, a Chinese herbal formula, as a food supplement to reduce the pain of patients with LBP induced by degeneration of the lumbar IVDs. Methods. The study assessed patient subjective quality of life, functional limitations caused by LBP, and variations in pain. The assessment was done through the visual analogue scale (VAS) and effects on lumbar IVD thickness, water content, and bone mineral density (BMD). These parameters were evaluated before and after the administration of Elgucare or a placebo, one of which was taken by each participant for a 12-month period. Results. Elgucare reduced the patients’ mean VAS pain score by 2.25 points and improved their mean LBP-hampered mobility as assessed by the Roland-Morris Questionnaire by 5.17 points. The results of another questionnaire indicated that Elgucare slowed the LBP-induced deterioration of patients’ quality of life, while objective assessment indices obtained through X-ray and magnetic resonance imaging showed that the height and water retention of their IVDs were increased. However, the BMD results showed no improvements. Conclusions. Elgucare can increase the water retention and height of IVDs and reduce LBP, thereby enhancing quality of life. Therefore, Elgucare can potentially be used as a clinical supplement.Wen-Cheng LoYu Ting ChenChen Ching ChenHindawi LimitedarticleComputer applications to medicine. Medical informaticsR858-859.7ENComputational and Mathematical Methods in Medicine, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Computer applications to medicine. Medical informatics
R858-859.7
spellingShingle Computer applications to medicine. Medical informatics
R858-859.7
Wen-Cheng Lo
Yu Ting Chen
Chen Ching Chen
The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
description Introduction. Chronic low back pain (LBP) has a wide range of causes. However, most cases are induced by degeneration of the lumbar intervertebral discs (IVDs), and the aching caused by local compression of the affected region has considerable impacts on quality of life. This clinical trial investigated the use of Elgucare, a Chinese herbal formula, as a food supplement to reduce the pain of patients with LBP induced by degeneration of the lumbar IVDs. Methods. The study assessed patient subjective quality of life, functional limitations caused by LBP, and variations in pain. The assessment was done through the visual analogue scale (VAS) and effects on lumbar IVD thickness, water content, and bone mineral density (BMD). These parameters were evaluated before and after the administration of Elgucare or a placebo, one of which was taken by each participant for a 12-month period. Results. Elgucare reduced the patients’ mean VAS pain score by 2.25 points and improved their mean LBP-hampered mobility as assessed by the Roland-Morris Questionnaire by 5.17 points. The results of another questionnaire indicated that Elgucare slowed the LBP-induced deterioration of patients’ quality of life, while objective assessment indices obtained through X-ray and magnetic resonance imaging showed that the height and water retention of their IVDs were increased. However, the BMD results showed no improvements. Conclusions. Elgucare can increase the water retention and height of IVDs and reduce LBP, thereby enhancing quality of life. Therefore, Elgucare can potentially be used as a clinical supplement.
format article
author Wen-Cheng Lo
Yu Ting Chen
Chen Ching Chen
author_facet Wen-Cheng Lo
Yu Ting Chen
Chen Ching Chen
author_sort Wen-Cheng Lo
title The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
title_short The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
title_full The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
title_fullStr The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
title_full_unstemmed The Effects of Elgucare on Degenerated Intervertebral Disc-Induced Low Back Pain and Disc Regeneration: A Clinical Trial
title_sort effects of elgucare on degenerated intervertebral disc-induced low back pain and disc regeneration: a clinical trial
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/907634213bff47689b46eb3977738594
work_keys_str_mv AT wenchenglo theeffectsofelgucareondegeneratedintervertebraldiscinducedlowbackpainanddiscregenerationaclinicaltrial
AT yutingchen theeffectsofelgucareondegeneratedintervertebraldiscinducedlowbackpainanddiscregenerationaclinicaltrial
AT chenchingchen theeffectsofelgucareondegeneratedintervertebraldiscinducedlowbackpainanddiscregenerationaclinicaltrial
AT wenchenglo effectsofelgucareondegeneratedintervertebraldiscinducedlowbackpainanddiscregenerationaclinicaltrial
AT yutingchen effectsofelgucareondegeneratedintervertebraldiscinducedlowbackpainanddiscregenerationaclinicaltrial
AT chenchingchen effectsofelgucareondegeneratedintervertebraldiscinducedlowbackpainanddiscregenerationaclinicaltrial
_version_ 1718418413180682240